KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Halozyme Therapeutics (HALO) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Halozyme Therapeutics (HALO) over the last 10 years, with Q4 2025 value amounting to $40.7 million.

  • Halozyme Therapeutics' Tax Provisions fell 111.65% to $40.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $150.0 million, marking a year-over-year increase of 3270.23%. This contributed to the annual value of $150.0 million for FY2025, which is 3268.28% up from last year.
  • As of Q4 2025, Halozyme Therapeutics' Tax Provisions stood at $40.7 million, which was down 111.65% from $43.7 million recorded in Q3 2025.
  • Halozyme Therapeutics' 5-year Tax Provisions high stood at $43.7 million for Q3 2025, and its period low was -$142.5 million during Q3 2021.
  • Over the past 5 years, Halozyme Therapeutics' median Tax Provisions value was $17.1 million (recorded in 2023), while the average stood at $11.1 million.
  • Per our database at Business Quant, Halozyme Therapeutics' Tax Provisions plummeted by 22626031.75% in 2021 and then skyrocketed by 1253103.45% in 2022.
  • Halozyme Therapeutics' Tax Provisions (Quarter) stood at -$12.0 million in 2021, then skyrocketed by 209.44% to $13.1 million in 2022, then rose by 20.61% to $15.8 million in 2023, then skyrocketed by 160.99% to $41.2 million in 2024, then dropped by 1.12% to $40.7 million in 2025.
  • Its Tax Provisions stands at $40.7 million for Q4 2025, versus $43.7 million for Q3 2025 and $39.8 million for Q2 2025.